Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-03-27

Clinical Trial Update: Bumetanide Versus Furosemide in Heart Failure [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing bumetanide to furosemide in heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUMETANIDE (bumetanide)
  • FUROSEMIDE (Furosemide)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Heart Failure | Phase 3 | Status: WITHDRAWN